Scarica l'app Stockscreener
210.83
0.75%
1.56
Pre-mercato:
210.00
-0.83
-0.39%
Precedente Chiudi:
$209.27
Aprire:
$215.96
Volume 24 ore:
1.09M
Relative Volume:
0.93
Capitalizzazione di mercato:
$29.88B
Reddito:
$2.31B
Utile/perdita netta:
$-208.16M
Rapporto P/E:
-137.21
EPS:
-1.5366
Flusso di cassa netto:
$76.11M
1 W Prestazione:
+3.75%
1M Prestazione:
+6.41%
6M Prestazione:
+22.51%
1 anno Prestazione:
+59.44%
Intervallo 1D:
$209.86
$220.00
Intervallo di 1 settimana:
$198.02
$220.00
Portata 52W:
$131.03
$256.36
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
210.83 | 29.88B | 2.31B | -208.16M | 76.11M | -1.5366 |
TMO
Thermo Fisher Scientific Inc
|
503.46 | 187.10B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
196.19 | 138.84B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
591.84 | 47.01B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
116.92 | 33.04B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
318.53 | 31.25B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Natera (NTRA) Wins Increased Royalty in Delaware Court Decision - GuruFocus
Natera Says Court Orders 30% Royalties From ArcherDx, Invitae on Post-Injunction Sales - marketscreener.com
Natera wins 30% ongoing royalty in patent case against Invitae By Investing.com - Investing.com India
Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents - Yahoo Finance
3 Reasons NTRA Has Explosive Upside Potential - TradingView
Natera (NASDAQ: NTRA) chair exercises options, uses shares for taxes - Stock Titan
Buy Signal: Can Natera Inc outperform in the next rallyWeekly Trend Recap & Short-Term Trading Alerts - baoquankhu1.vn
Natera Inc. (NTRA): Upside Potential Pulls Billionaire Stan Druckenmiller - Insider Monkey
Natera Award Cut by $10 Million as Invitae Faces Royalty (1) - Bloomberg Law News
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform - BioSpace
Natera (NTRA) Gets 90-Day Catalyst Watch from Citi and Maintains Buy Rating - GuruFocus
56,665 Shares in Natera, Inc. $NTRA Purchased by Robinhood Asset Management LLC - MarketBeat
Natera, Inc. (NTRA) stock price, news, quote and history - Yahoo Finance Singapore
Judge Slashes Damages For Natera In Invitae Patent Case - Law360
Natera, Inc. (NTRA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assessing Natera (NTRA) Valuation After New Signatera Breast Cancer Study Results - simplywall.st
Insider Sell Alert: Daniel Rabinowitz Sells 8,400 Shares of Nate - GuruFocus
Natera (NASDAQ:NTRA) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Natera SEC. sold $1.7m in NTRA stock By Investing.com - Investing.com Canada
Natera (NASDAQ:NTRA) Insider Solomon Moshkevich Sells 3,000 Shares of Stock - marketbeat.com
Natera president sells $606,899 in NTRA stock - Investing.com
Natera SEC. sold $1.7m in NTRA stock - Investing.com
Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 plan - Stock Titan
Natera president sells $606,899 in NTRA stock By Investing.com - Investing.com India
Insiders At Natera Sold US$40m In Stock, Alluding To Potential Weakness - 富途牛牛
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Natera (NTRA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Natera Expands Board, Appoints Eric Rubin as Director - theglobeandmail.com
Natera sec. and chief legal officer sells $307k in stock - Investing.com
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
Natera, Inc. $NTRA Shares Sold by SWS Partners - MarketBeat
Natera, Inc. Files Form 8-K Reporting Company Details and Regulatory Compliance as of March 26, 2026 - Minichart
Natera (NTRA) chair exercises 41,708 options, now holds 2.35M shares - Stock Titan
Natera Jumps After Exceeding Earnings Expectations and Unprecedented Institutional Purchases Even as Insiders Sell - bitget.com
Natera appoints Eric Rubin to board, expands board size to eleven members By Investing.com - Investing.com Canada
Natera appoints Eric Rubin to board, expands board size to eleven members - Investing.com
Eric Rubin appointed to Natera board as Class I director - TradingView
Natera, Inc. Appoints Eric Rubin to the Board and Member of Nominating, Corporate Governance and Compliance Committee, Effective March 26, 2026 - marketscreener.com
Eric Rubin joins Natera (NASDAQ: NTRA) board as independent director - Stock Titan
Solomon Moshkevich files Form 144; 3,000 Performance Shares (NTRA) - Stock Titan
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
J. Safra Sarasin Holding AG Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera (NTRA) - simplywall.st
Natera, Inc. $NTRA Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery - Benzinga
Avoiding Lag: Real-Time Signals in (NTRA) Movement - Stock Traders Daily
Natera, Inc. $NTRA Shares Sold by Zevenbergen Capital Investments LLC - MarketBeat
Why Natera Stock Is Surging Despite Recent Volatility - TipRanks
Blood test helped some women over 70 with breast cancer avoid surgery - Stock Titan
SG Americas Securities LLC Reduces Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas - MSN
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):